Testing version — LOERadar is in active testing. Features and data may change.
PEDIATRIC ADVIL (IBUPROFEN) | LOERadar
PEDIATRIC ADVIL
NDA
IBUPROFEN | N020812 | HALEON US HOLDINGS LLC
2 strengths0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (2)
Sort:
#002 — 50MG/1.25ML
RLD
0 patents0 exclusivities▾
SUSPENSION/DROPS;ORAL | Approved: Jan 12, 2000
#001 — 100MG/2.5ML
RLD
0 patents0 exclusivities▴
SUSPENSION/DROPS;ORAL | Approved: Jan 30, 1998
No patent or exclusivity listings for this strength.